Full-Time

Senior Global Medical Affairs Leader-Obesity

Posted on 4/11/2025

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior

Boston, MA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Masters degree with 5+ years of experience in the pharmaceutical industry (Medical, Marketing, R&D, Market access roles), or experience working within a relevant health system setting (clinical, pharmacy, pathway design etc.)
  • Experienced Business leader (e.g. led a TA/franchise in a market, driven brand performance, led large teams) able to deliver results in a complex environment
  • Deep healthcare system pathways/market-shaping experience and understanding (e.g. led transformation programs in healthcare systems, driven partnerships from a pharma perspective)
  • Proven ability to build internal and external networks and to collaborate across geographies and cultures
  • Substantial evidence generation/data expertise, e.g. clinical trial experience (conducted Ph2, Ph3 or Ph4 studies), and/or substantial RWE experience (world-class registry, experience with RWE for label enhancement, practice-changing RWD usage)
Responsibilities
  • Design and lead the implementation of product and disease area strategies and practice change initiatives at a global level, partnering to ensure execution at a regional/country level.
  • Develop novel solutions to shape/define a market in preparation for launch.
  • Design and leverage high-impact evidence activities in support of product and disease area strategies and practice change initiatives; optimize the communications roll-out of our data sets and be an ambassador for our practice-changing evidence.
  • Craft and convey a compelling narrative across product and disease area strategies, in line with our Medical ambition.
  • Engage and cultivate relationships with leading global thought leaders, societies, patient organizations, and health systems to partner effectively to optimize patient care.
  • Initiate and lead new partnerships across the healthcare ecosystem from an AZ perspective.
Desired Qualifications
  • Doctoral level degree: MD, PhD, or PharmD
  • Expertise in either Obesity, T2DM or cardio-renal disease
  • Relevant experience beyond Medical affairs (e.g. in a marketing/R&D/Market Access role)
  • Strong working relationships with global thought leaders, including key experts and opinion leaders, professional societies, and other healthcare industries/organizations
  • Experience launching new products or indications, and in developing and launching medicines in key geographies (e.g US, China)

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatments; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before they reach the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency and innovation.
  • Real-world evidence supports AstraZeneca's drug efficacy and safety demonstrations.
  • Personalized medicine aligns with AstraZeneca's focus on precision oncology treatments.

What critics are saying

  • Class-action lawsuit over Soliris could lead to financial penalties and reputational damage.
  • AI tool for breast cancer screening may face challenges due to minority underrepresentation.
  • Investment in Dunkirk production lines may be affected by changes in French regulations.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing resources with the scientific community.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

Europawire
Apr 8th, 2025
AstraZeneca Unveils Breakthrough Data on Vaccines and Antibody Therapies for Infections

AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.

INACTIVE